Price DeMonty
Known title: DirectorCIK: 0001673961
Price DeMonty's purchase track record
How the stock did after each of Price DeMonty's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since February 21, 2025
Stock higher 6 months later
67%
3 months: 67%
Median 6-month return
+6.1%
3 months: +8.7%
Beat the S&P 500
33%
median -3.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/7/2025 | WWW | $394K | +17.4% | +6.1% | +10.0% |
| 8/8/2025 | WWW | $408K | -41.8% | -31.6% | +8.5% |
| 2/21/2025 | WWW | $536K | +8.7% | +105.2% | +7.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| WWW | ▲ Buy | Open Market | 25,000 | $394K | 11/7/2025 | View on chart |
| WWW | ▲ Buy | Open Market | 15,000 | $408K | 8/8/2025 | View on chart |
| WWW | ▲ Buy | Open Market | 35,000 | $536K | 2/21/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Wolverine (WWW) Sees Momentum Amid Birkenstock Growth
Recent reports highlight Wolverine World Wide's fast-paced momentum, attributing it to strong growth at its Birkenstock brand. This performance is seen by some analysts as a potential value opportunity despite the stock's current position. The company's valuation, with a trailing P/E of 13.9, remains below the average analyst target price of $24.30.
Wolverine (WWW) Sees Momentum Amid Birkenstock Growth. Recent reports highlight Wolverine World Wide's fast-paced momentum, attributing it to strong growth at its Birkenstock brand. This performance is seen by some analysts as a potential value opportunity despite the stock's current position. The company's valuation, with a trailing P/E of 13.9, remains below the average analyst target price of $24.30.